Amnog Benefit Assessment: Time Delay of Market Access for Pharmaceuticals in Germany?

Saved in:
Bibliographic Details
Published in:Value in health Vol. 16; no. 7; p. A475
Main Authors: Neubauer, A.S, Voss, P, Gmeiner, A, Neubauer, G
Format: Journal Article
Language:English
Published: 01-11-2013
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Author Voss, P
Gmeiner, A
Neubauer, A.S
Neubauer, G
Author_xml – sequence: 1
  fullname: Neubauer, A.S
– sequence: 2
  fullname: Voss, P
– sequence: 3
  fullname: Gmeiner, A
– sequence: 4
  fullname: Neubauer, G
BookMark eNotkMFOwzAQRH0oEm3hBzj5BxK8dpykHEClQEEqAon2bDnuGpI2DrLbSvl7HJXTSqOZ0eybkJHrHBJyAywFBvltkzYnvU85A5GyMi1LOSJjYLMyEQzkJZmE0DDGcsHlmGzmreu-6SM6tPWBzkPAEFp0hzu6rlukT7jXPe0sfdd-h9FgTDRQ23n6-aN9qw0eD7XR-0BrR5cYFdc_XJELGyW8_r9Tsnl5Xi9ek9XH8m0xXyUGMi4TyNBwU0KFUHIOspICgJlCYmU4csurvMqlKLa5zdAWYltYzAVWWlZZYbKZmBJ-7jW-C8GjVb--brXvFTA1wFCNGmCoAYZipYowYuj-HMK47FSjV2Zfu-GHHfYYmu7oXRytQAWumPoa0A3kQDBezJgQfx1FbJw
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1016/j.jval.2013.08.885
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EndPage A475
ExternalDocumentID 10_1016_j_jval_2013_08_885
1_s2_0_S1098301513027903
GroupedDBID ---
--K
--M
.1-
.3N
.FO
.GA
.Y3
.~1
0R~
0SF
10A
123
1OC
1P~
1~.
29Q
31~
36B
4.4
44B
457
4G.
51W
51X
52N
52P
52R
52S
52X
53G
5LA
5VS
66C
6I.
6PF
7-5
7PT
8-1
8P~
8UM
AACTN
AAEDT
AAEDW
AAFJI
AAFTH
AAFWJ
AAHHS
AAIKJ
AAKOC
AALRI
AAOAW
AAPFB
AAQFI
AAQXK
AAWTL
AAXKI
AAXUO
ABBQC
ABCQN
ABDBF
ABEML
ABIVO
ABJNI
ABMAC
ABMMH
ABMZM
ABVKL
ABXDB
ACCFJ
ACDAQ
ACGFS
ACHQT
ACPRK
ACRLP
ACXQS
ADBBV
ADEZE
ADFHU
ADMUD
ADVLN
AEBSH
AEEZP
AEKER
AENEX
AEQDE
AEVXI
AEXQZ
AEYQN
AFBPY
AFCTW
AFEBI
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AFZJQ
AGHFR
AGTHC
AGUBO
AGYEJ
AIEXJ
AIIAU
AIKHN
AITUG
AIWBW
AJAOE
AJBDE
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AOMHK
ASPBG
AVARZ
AVWKF
AXJTR
AXLSJ
AZFZN
BAWUL
BFHJK
BKOJK
BLXMC
BNPGV
BY8
CAG
CO8
COF
CS3
DCZOG
DIK
DU5
EAD
EAP
EBS
EFJIC
EJD
EMB
EMK
EMOBN
ESX
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
GBLVA
HF~
HVGLF
HZI
HZ~
IHE
IXB
KOM
M41
MO0
N9A
NCXOZ
O-L
O9-
OAUVE
OIG
OK1
OVD
P-8
P-9
P2P
PC.
PQQKQ
PRBVW
Q38
QB0
R2-
RIG
ROL
SDF
SEL
SES
SPCBC
SSB
SSF
SSH
SSO
SSZ
SUPJJ
SV3
T5K
TEORI
TUS
W99
WYUIH
XG1
YFH
Z5R
~G-
AAYXX
CITATION
ID FETCH-LOGICAL-c1425-14ec2c81be182215b53110c75ebc2e2f2b6b6537d6f4ef73d7fe63eba5b47c493
ISSN 1098-3015
IngestDate Thu Sep 26 17:10:55 EDT 2024
Tue Oct 15 22:56:05 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1425-14ec2c81be182215b53110c75ebc2e2f2b6b6537d6f4ef73d7fe63eba5b47c493
OpenAccessLink http://www.valueinhealthjournal.com/article/S1098301513027903/pdf
ParticipantIDs crossref_primary_10_1016_j_jval_2013_08_885
elsevier_clinicalkeyesjournals_1_s2_0_S1098301513027903
PublicationCentury 2000
PublicationDate 2013-11-00
PublicationDateYYYYMMDD 2013-11-01
PublicationDate_xml – month: 11
  year: 2013
  text: 2013-11-00
PublicationDecade 2010
PublicationTitle Value in health
PublicationYear 2013
SSID ssj0006325
Score 2.0658183
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage A475
SubjectTerms Internal Medicine
Title Amnog Benefit Assessment: Time Delay of Market Access for Pharmaceuticals in Germany?
URI https://www.clinicalkey.es/playcontent/1-s2.0-S1098301513027903
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLe6TUJcEAwQ40s-oF26VEnsxAkXFEboAIEmrUO7WbVjQ6s1RWQ59L_nOXY-1g0JkLikrZVE7nu__J6f8z4QeiVCosBKB14UmJQcWVAvlfPYE6IIqRSMyaZk_skZ-3KRvMtpPhq1HcD6sf-qaRgDXZvM2b_QdndTGIDvoHM4gtbh-Ed6z1bl-tv4LVCYXlyNs67wZrOPvliZMKHL-cZGvpiEZ9MvwrCdCTc8_T7c4G4iZaeGucvNVvzf1_ll3VQbsWmU_Y5yLea164896Zt5uc7sXSrZdKUWLtEmu-3a6XAvIiAuKa-nT1OdFCgjusav8QBHbECWGbVNU5zhbX_eIHW7v7CcLEEbJhiPmKKrSRL1Jqx9bZ8ffwq8Kpz43pmZiplJ82I29cn1k63_w6uQ-_zGqTtoDz4J8OVe9iG_-NhZ9pg0TXy7f-mSsGy84Pbsbl_oDBYvs_vonvM6cGbh8gCNVLmP7nx2cRX76NBpfnOEZ31CXnWED_FpX9t88xCdN_DCDl64h9drbMCFG3DhtcYWXNiCCwO48Ba48KLEDlxvHqHz9_ns-MRznTk8GQDJewFVMpTg8ShwT2HRKIDJA1-ySAkZqlCHIhZxRFgRa6o0IwXTKiZKzCNBmaQpeYx2y3WpniBM_aZPEhGF0lTKKEl9nYbgJUgttaL6AI1bMfIftgALbyMTl9wInRuhcz_hIPQDxFpJ8za1GIyhqtwTWvHfKf3pP1_5DN3tn4XnaPfqZ61eoJ2qqF86AP0CEvmOPg
link.rule.ids 315,783,787,27936,27937
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Amnog+Benefit+Assessment%3A+Time+Delay+of+Market+Access+for+Pharmaceuticals+in+Germany%3F&rft.jtitle=Value+in+health&rft.au=Neubauer%2C+A.S&rft.au=Voss%2C+P&rft.au=Gmeiner%2C+A&rft.au=Neubauer%2C+G&rft.date=2013-11-01&rft.issn=1098-3015&rft.volume=16&rft.issue=7&rft.spage=A475&rft.epage=A475&rft_id=info:doi/10.1016%2Fj.jval.2013.08.885&rft.externalDBID=ECK1-s2.0-S1098301513027903&rft.externalDocID=1_s2_0_S1098301513027903
thumbnail_m http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10983015%2FS1098301513X00075%2Fcov150h.gif